Wegener's granulomatosis.
D000477:Alkylating Agents / Q000627:therapeutic use; D000936:Antigen-Antibody Complex; D000963:Antimetabolites / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D006103:Granuloma, Lethal Midline / Q000276:immunology; D014890:Granulomatosis with Polyangiitis / Q000188:drug therapy / Q000276:immunology / Q000532:radiotherapy; D006801:Humans; D007668:Kidney / Q000276:immunology; D007674:Kidney Diseases / Q000276:immunology; D011379:Prognosis
D000477:Alkylating Agents; D000936:Antigen-Antibody Complex; D000963:Antimetabolites; D000970:Antineoplastic Agents